You are here:

Archived: Pregabalin 25, 50, 75, 100, 150, 200 and 300mg capsules (Lyrica)

Advice

Following an Independent Review Panel Assessment

pregabalin (Lyrica®) is not recommended for use within NHS Scotland for the treatment of peripheral neuropathic pain in adults.

Comparative clinical and cost effectiveness have not been demonstrated.

Further controlled data are needed to establish its place in therapy in patients refractory to or intolerant of other pharmacological treatments.

Drug Details

Drug Name: Pregabalin 25, 50, 75, 100, 150, 200 and 300mg capsules (Lyrica)
SMC Drug ID: 157/05
Manufacturer: Pfizer Ltd
Indication: Peripheral neuropathic pain in adults
BNF Category:
Sub Category: 4.8 Antiepileptic drugs
Submission Type: IRP
Status: Not Recommended
Date Advice Published: 7 August 2006

Current Advice

Resubmission 11 May 2009

Archived Advice

Resubmission 15 August 2005
Full submission 7 March 2005

Back